Investigating how specific cell signaling affects brain injury recovery in mice
Cell Specific RIPK3 Signaling After Traumatic Brain Injury in Mice
This study is looking at how a protein called RIPK3 affects recovery after a brain injury in mice, to help us find new ways to improve healing and brain function for people who have experienced similar injuries.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11059983 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of receptor interacting protein kinase 3 (RIPK3) in the recovery process following traumatic brain injury in mice. By using genetic tools and a controlled cortical impact model, the study examines how the absence of RIPK3 influences motor and cognitive functions after brain injury. The researchers isolate specific brain cell populations to analyze the expression of RIPK3 and its effects on inflammation and neuronal health. The findings aim to uncover potential therapeutic targets for improving recovery from brain injuries.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced traumatic brain injuries, particularly those with age-related neurodegenerative conditions.
Not a fit: Patients with non-traumatic brain injuries or those without significant neurological impairment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that enhance recovery from traumatic brain injuries.
How similar studies have performed: Previous research has shown promising results in understanding the role of RIPK1 in brain injury, suggesting that exploring RIPK3 could yield valuable insights, although this specific approach is less studied.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Whalen, Michael J — Massachusetts General Hospital
- Study coordinator: Whalen, Michael J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.